M

myTomorrows

Clinical trial recruitment and access platform

Director of Pharma Partnerships - Expanded Access

Business Development & PartnershipsPosted on Nov 12
Full-timeNo salary listed

About the Job

Requirements

  • A Master's degree in Business Administration, Life Science, or Healthcare is required; a Bachelor's degree is considered with strong experience.
  • At least 5 years of experience in partnership development, business development, or sales, focused on contracting and closing deals in the pharmaceutical industry.
  • An existing pharmaceutical industry network, preferably in medical affairs, market access, regulatory affairs, and Expanded Access.
  • A proven record of meeting or exceeding sales targets and closing high-value deals.
  • Strong understanding of Expanded Access, Named Patient Sales pricing and reimbursement, and Expanded Access regulatory frameworks in Europe and other key markets.
  • Excellent negotiation, communication, and presentation skills in English.
  • Deep understanding of the full sales cycle, from lead generation through contract negotiation and post-deal expansion.
  • Ability to identify market opportunities and develop actionable plans.
  • Daily use of AI tools to research, verify, and document work efficiently without compromising accuracy.
  • Ability to work independently and collaboratively in a fast-paced environment and lead cross-functional initiatives.

Responsibilities

  • Network and generate leads, supported by a Pharma Partnerships Associate.
  • Develop and execute a partnership strategy to acquire new partners for chargeable Expanded Access Programs and expand existing pharmaceutical industry relationships.
  • Meet and exceed partnership targets and sales quotas to drive revenue growth.
  • Qualify deals, negotiate agreements, and close multi-year Expanded Access Program partnerships aligned with company objectives.
  • Own quarterly and annual revenue targets, with accountability for pipeline conversion and deal velocity.
  • Work with the Directors of Expanded Access Strategy and Global Access to build cases for chargeable programs with BioPharma clients by identifying countries and pathways where treatment charging is allowed and designing pricing, country selection, regulatory approach, and supply model.
  • Lead proposals and bid defenses with Expanded Access Strategy, Global Access, and Finance.
  • Coordinate with Expanded Access Program Operations and Global Access on handovers and implementation of partnership commitments.
  • Identify upsell and cross-sell opportunities, including converting free-of-charge programs to chargeable models, adding countries or assets, post-trial access, real-world data, and patient recruitment; support contracting for expansions.
  • Support development of sales enablement materials with Product Marketing.
  • Represent the company externally as a thought leader in Expanded Access through industry presence, conference talks, and high-quality content.
  • Track and manage pipeline activities in HubSpot and maintain accurate reporting and forecasting.
  • Monitor industry trends, regulatory developments, and competitor activities to identify growth and differentiation opportunities.
  • Travel to clients, conferences, and prospects globally, up to 60% of the time.

Desired Qualifications

  • Pharmaceutical industry connections in medical affairs, market access, regulatory affairs, and Expanded Access are preferred.

About the Company

myTomorrows

Clinical trial recruitment and access platform

myTomorrows connects patients with serious diseases to BioPharma companies developing new treatments through a platform that coordinates patient recruitment for clinical trials, expanded access, and Real World data collection. The platform links patients, healthcare professionals, and pharma teams in one hub to discover trial options, access programs, and manage enrollment and data collection. Revenue comes from partnerships with BioPharma companies that pay for these services to recruit patients faster and obtain real-world insights. Its goal is to shorten the time to bring new treatments to patients by simplifying access, enrollment, and real‑world evidence gathering across patients, clinicians, and pharma.

Company size
51-200
Company stage
Late Stage VC
Total funding
$51M
Headquarters
Amsterdam, Netherlands
Founded
2012

Recently Posted Jobs

Explore more opportunities at myTomorrows

See more jobs